http://rdf.ncbi.nlm.nih.gov/pubchem/patent/PL-176409-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cf32b60391b469c41e86c353437f5751
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-535
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-18
filingDate 1994-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2804ee9a9daf3ebc14cff4ca9b719c25
publicationDate 1999-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber PL-176409-B1
titleOfInvention Tetrahydropyran derivatives, the method of their preparation and the pharmaceutical composition containing them
abstract CLAIMS 1. Tetrahydropyran derivatives of formula I in which R 1 is a group of formula 2 or 3, in which or R 7 is optionally protected hydroxyl, acyloxy, halogen, -OR 10, in which R 10 is lower alkyl, optionally protected by the -O (CH2) mOH group, where m is a number 2-4, or the group -OCONH2, and R7a is hydrogen, or R7 and R7a together are oxo, R8 is a hydroxyl or methoxy group, and R9 is hydroxy or acyloxy; R2 is hydrogen, acyloxy, or an optionally substituted hydroxy group, and there is a single or double bond between the two carbon atoms joined by a dashed line; R 3 is methyl, ethyl, n-propyl, or allyl; or R 4 is hydrogen or hydroxy and R 4a is hydrogen, or R 4 and R 4a together are oxo; or R 5 is hydroxy and R 5a is hydrogen, or R 5 and R 5a together are oxo; and A is a group of formula -CH (OR 6) -CH2- (CN2) n- or -CH = CH- (CH2) n-, in which the (CH2) n- portion is attached to the carbon atom, R6 is the lower group alkyl and n is 1 or 2; in free form, and wherever they exist, in salt form. PATTERN 1 PL
priorityDate 1993-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID70763
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419488216
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID27435
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421133794
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449949725
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425193155
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458397310
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419567187
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6264
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559516
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419516664
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393787
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393726
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559581
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458392451
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID783
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457655803
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68494755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454388162
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID253881

Total number of triples: 39.